Market Activity for Neurizon Therapeutics Ltd. (NUZTF)
Neurizon Therapeutics Ltd. (NUZTF) has recently made headlines with a notable increase in its stock price. Trading at $0.11, the stock has risen by 22.22% or $0.02 from its previous value. The best bid and ask prices were recorded at $0.06 and $30.22 respectively.
Real-Time Market Data
The real-time best bid and ask were noted at 05:00 PM on February 26, 2026, while the delayed trade data for the same day was recorded at 12:00 AM.
Latest News
On February 25, 2026, news broke that Neurizon has initiated dosing in the HEALEY ALS Platform Trial, signaling an important step in their research and development efforts.
Company Profile
Neurizon Therapeutics Ltd. is committed to innovation in the biotechnology sector. The company has confirmed its eligibility to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b) and has a verified profile as of January 2026.
Corporate Governance
The board of directors at Neurizon includes at least two Independent Directors, ensuring a balanced governance structure.
Daily Advancers
In today's trading, notable daily advancers include:
- LDXC: +508.00%
- EUBGD: +159.20%
- GEDC: +146.26%
- SCTH: +113.33%
- TSDRF: +110.18%
Stay updated on the latest developments in the market by subscribing to our newsletter. You can also check out more about Neurizon and its stock performance at Inside Ticker.